— Know what they know.
Not Investment Advice
Also trades as: SAN.PA (PAR) · $vol 173M · SNY (NASDAQ) · $vol 137M · SNW.DE (XETRA) · $vol 1M · SNY.TO (TSX) · $vol 0M

SNYNF Institutional Ownership

Sanofi
1W: +4.0% 1M: +3.1% 3M: -8.1% YTD: -15.1% 1Y: -19.0% 3Y: -12.2% 5Y: -0.9%
$83.43
-1.39 (-1.64%)
Pre-Market: $83.86 (+0.43, +0.52%)
OTC · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 62 · $100.1B mcap · 1.09B float · 0.0023% daily turnover · Short 45% of daily vol
Credit Risk of going bust: lower than 81% of companies Debt: 20.7% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.34 (down 98%), Sanofi would be worth roughly what it owes.
Total debt $26.24B against a stock market value of $100.37B.
Distance to default 10.01 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $15.97B (short-term plus half of long-term), stock volatility 23.1%; Altman Z'' 1.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

No institutional holdings data available for SNYNF

Institutional holdings are sourced from SEC 13F filings and may not be available for all securities.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms